Date: Friday, Jun 14, 2019
Description: Dr. Kahn helps participants understand the link between the gut microbiome and cardiovascular risk, know the role of trimethylene N-oxide (TMAO) as an indicator of cardiovascular (CVD) risk and identify ways to uncover and manage CVD risk with advanced testing, including TMAO. At the end of the presentation, participants will be able to: • Understand the link between the gut microbiome and cardiovascular risk • Know the role of trimethylene N-oxide (TMAO) as an indicator of cardiovascular (CVD) risk • Identify ways to uncover and manage CVD risk with advanced testing, including TMAO ASCLS P.A.C.E.® credits are available to laboratory professionals through December 4, 2019.
Author:
Kahn, Joel, MD, FACC
Founder
Kahn Center for Cardiac Longevity
Clinical Professor of Medicine
Wayne State University School of Medicine
Detroit, Michigan